Up and running again

A Boston Scientific therapy helped Esther overcome cancer pain.

Read her story

Featured stories

Our site in Kerkrade, the Netherlands, shows how our renewable energy strategy is paying off.

Learn how the pump, and penile prosthesis implants, work.

Oct 30, 2024

Turning a great idea into reality doesn’t happen in a vacuum. It requires a strong company culture.

Read more stories

Press releases
Jan 16, 2025

First phase of ADVANTAGE AF clinical trial achieves safety and effectiveness endpoints for treatment of drug-resistant, symptomatic, persistent atrial fibrillation with the FARAPULSE™ Pulsed...

Jan 8, 2025

Boston Scientific Corporation (NYSE: BSX) announced today that Miriam O’Sullivan has been promoted to senior vice president and chief human resources officer at Boston Scientific. Miriam...

Jan 8, 2025

Bolt Medical acquisition to expand cardiovascular portfolio, furthering Boston Scientific strategy to address coronary and peripheral artery disease.

Read more press releases

In the news
Dec 11, 2024
Today's Marketplace
Ken Stein, MD, senior vice president and global chief medical officer, discuss health inequities and Boston Scientific's work to improve access to care for underserved populations.
Dec 6, 2024
Health Day
Boston Scientific presented a study at the 23rd American Society of Regional Anesthesia and Pain Medicine Meeting that demonstrates Fast-Acting Sub-Perception Therapy (FAST), with the WaveWriter spinal cord stimulation systems, as a breakthrough solution that significantly reduces chronic pain and improves patient outcomes with high satisfaction for up to 12 months, and no increase in opioid use during the primary endpoint interval.
Dec 2, 2024
Forbes
Jodi Euerle Eddy, chief information and digital officer, shares the importance of interdepartmental collaboration in creating a culture of innovation that supports the investment, deployment and successful adoption of new technology.
Nov 30, 2024
The Minnesota Star Tribune
As the number of people diagnosed with atrial fibrillation (AF) rises around the world, Ken Stein, MD, senior vice president and global chief medical officer and Nick Spadea-Annello, global president, Electrophysiology, along with industry experts, offer the Star Tribune perspective on the paradigm shift to pulsed field ablation for the treatment of AF, the explosive growth of the FARAPULSE™ Pulsed Field Ablation System, the competitive innovation race and the future of cardiac care.

Read more news

2023 Performance Report

When science, humanity and purpose connect, lives can be transformed

View the Report

Sign up to receive our press releases via email

Business and enterprise contacts for journalists

Imagery and other resources

Top